{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,4]],"date-time":"2026-10-04T03:48:35Z","timestamp":1791085715047,"version":"4.1.0"},"reference-count":52,"publisher":"Elsevier BV","issue":"12","license":[{"start":{"date-parts":[[2004,12,1]],"date-time":"2004-12-01T00:00:00Z","timestamp":1101859200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Leukemia Research"],"published-print":{"date-parts":[[2004,12]]},"DOI":"10.1016\/j.leukres.2004.03.019","type":"journal-article","created":{"date-parts":[[2004,6,8]],"date-time":"2004-06-08T16:41:10Z","timestamp":1086712870000},"page":"1293-1301","source":"Crossref","is-referenced-by-count":11,"title":["Methylation status of cyclin-dependent kinase inhibitor genes within the transforming growth factor beta pathway in human T-cell lymphoblastic lymphoma\/leukemia"],"prefix":"10.1016","volume":"28","author":[{"given":"Stuart A.","family":"Scott","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tomofumi","family":"Kimura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei-Feng","family":"Dong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ryo","family":"Ichinohasama","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Susan","family":"Bergen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Annette","family":"Kerviche","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Sheridan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John F.","family":"DeCoteau","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.leukres.2004.03.019_BIB1","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/S0889-8588(05)70200-8","article-title":"Lymphoblastic lymphoma","volume":"15","author":"Thomas","year":"2001","journal-title":"Hematol Oncol Clin North Am"},{"key":"10.1016\/j.leukres.2004.03.019_BIB2","doi-asserted-by":"crossref","first-page":"4576","DOI":"10.1074\/jbc.272.7.4576","article-title":"Transcriptional activity of TAL1 in T cell acute lymphoblastic leukemia (T-ALL) requires RBTN1 or -2 and induces TALLA1, a highly specific tumor marker of T-ALL","volume":"272","author":"Ono","year":"1997","journal-title":"J Biol Chem"},{"key":"10.1016\/j.leukres.2004.03.019_BIB3","doi-asserted-by":"crossref","first-page":"666","DOI":"10.1182\/blood.V86.2.666.bloodjournal862666","article-title":"Does activation of the TAL1 gene occur in a majority of patients with T-cell acute lymphoblastic leukemia? A childhood oncology group study","volume":"86","author":"Bash","year":"1995","journal-title":"Blood"},{"key":"10.1016\/j.leukres.2004.03.019_BIB4","first-page":"2389","article-title":"T-cell acute lymphoblastic lymphoma induced in transgenic mice by the RBTN1 and RBTN2 LIM-domain genes","volume":"7","author":"Fisch","year":"1992","journal-title":"Oncogene"},{"key":"10.1016\/j.leukres.2004.03.019_BIB5","doi-asserted-by":"crossref","first-page":"209","DOI":"10.3109\/10428199509049759","article-title":"Dysregulation of HOX11 by chromosome translocations in T-cell acute lymphoblastic leukemia: a paradigm for homeobox gene involvement in human cancer","volume":"16","author":"Lichty","year":"1995","journal-title":"Leuk Lymphoma"},{"key":"10.1016\/j.leukres.2004.03.019_BIB6","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1038\/35043051","article-title":"How cells read TGF-beta signals","volume":"1","author":"Massague","year":"2000","journal-title":"Nat Rev Mol Cell Biol"},{"key":"10.1016\/j.leukres.2004.03.019_BIB7","doi-asserted-by":"crossref","first-page":"1350","DOI":"10.1056\/NEJM200005043421807","article-title":"Role of transforming growth factor beta in human disease","volume":"342","author":"Blobe","year":"2000","journal-title":"N Engl J Med"},{"key":"10.1016\/j.leukres.2004.03.019_BIB8","doi-asserted-by":"crossref","first-page":"1336","DOI":"10.1126\/science.7761852","article-title":"Inactivation of the type II TGF-beta receptor in colon cancer cells with microsatellite instability","volume":"268","author":"Markowitz","year":"1995","journal-title":"Science"},{"key":"10.1016\/j.leukres.2004.03.019_BIB9","first-page":"320","article-title":"Mutational inactivation of transforming growth factor beta receptor type II in microsatellite stable colon cancers","volume":"59","author":"Grady","year":"1999","journal-title":"Cancer Res"},{"key":"10.1016\/j.leukres.2004.03.019_BIB10","first-page":"4420","article-title":"Frameshift somatic mutations in gastrointestinal cancer of the microsatellite mutator phenotype","volume":"57","author":"Yamamoto","year":"1997","journal-title":"Cancer Res"},{"key":"10.1016\/j.leukres.2004.03.019_BIB11","first-page":"2995","article-title":"Frameshift mutations at mononucleotide repeats in caspase-5 and other target genes in endometrial and gastrointestinal cancer of the microsatellite mutator phenotype","volume":"59","author":"Schwartz","year":"1999","journal-title":"Cancer Res"},{"key":"10.1016\/j.leukres.2004.03.019_BIB12","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1016\/S0145-2126(00)00121-1","article-title":"Corrigendum to: Frequent microsatellite instability and BAX mutations in T cell acute lymphoblastic leukemia cell lines","volume":"25","author":"Inoue","year":"2001","journal-title":"Leuk Res"},{"key":"10.1016\/j.leukres.2004.03.019_BIB13","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/S0145-2126(02)00078-4","article-title":"Microsatellite mutations of transforming growth factor-\u03b2 receptor type II and caspase-5 occur in human precursor T-cell lymphoblastic lymphomas\/leukemias in vivo but are not associated with hMSH2 or hMLH1 promoter methylation","volume":"27","author":"Scott","year":"2003","journal-title":"Leuk Res"},{"key":"10.1016\/j.leukres.2004.03.019_BIB14","doi-asserted-by":"crossref","first-page":"1767","DOI":"10.1182\/blood.V95.5.1767.005k07_1767_1772","article-title":"MSH2-deficient murine lymphomas harbor insertion\/deletion mutations in the transforming growth factor beta receptor type 2 gene and display low not high frequency microsatellite instability","volume":"95","author":"Lowsky","year":"2000","journal-title":"Blood"},{"key":"10.1016\/j.leukres.2004.03.019_BIB15","first-page":"8331","article-title":"Heterogeneous transforming growth factor (TGF)-beta unresponsiveness and loss of TGF-beta receptor type II expression caused by histone deacetylation in lung cancer cell lines","volume":"61","author":"Osada","year":"2001","journal-title":"Cancer Res"},{"key":"10.1016\/j.leukres.2004.03.019_BIB16","doi-asserted-by":"crossref","first-page":"35053","DOI":"10.1074\/jbc.274.49.35053","article-title":"Transforming growth factor-beta-mediated p15INK4B induction and growth inhibition in astrocytes is SMAD3-dependent and a pathway prominently altered in human glioma cell lines","volume":"274","author":"Rich","year":"1999","journal-title":"J Biol Chem"},{"key":"10.1016\/j.leukres.2004.03.019_BIB17","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1038\/371257a0","article-title":"p15INK4B is a potential effector of TGF-beta-induced cell cycle arrest","volume":"371","author":"Hannon","year":"1994","journal-title":"Nature"},{"key":"10.1016\/j.leukres.2004.03.019_BIB18","doi-asserted-by":"crossref","first-page":"29244","DOI":"10.1074\/jbc.M909467199","article-title":"Role of Smad proteins and transcription factor Sp1 in p21(waf1\/Cip1) regulation by transforming growth factor-beta","volume":"275","author":"Pardali","year":"2000","journal-title":"J Biol Chem"},{"key":"10.1016\/j.leukres.2004.03.019_BIB19","doi-asserted-by":"crossref","first-page":"5926","DOI":"10.1038\/sj.onc.1203991","article-title":"Disruption of TGF-beta growth inhibition by oncogenic ras is linked to p27Kip1 mislocalization","volume":"19","author":"Liu","year":"2000","journal-title":"Oncogene"},{"key":"10.1016\/j.leukres.2004.03.019_BIB20","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1146\/annurev.med.50.1.401","article-title":"The prognostic significance of altered cyclin-dependent kinase inhibitors in human cancer","volume":"50","author":"Tsihlias","year":"1999","journal-title":"Annu Rev Med"},{"key":"10.1016\/j.leukres.2004.03.019_BIB21","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1038\/sj.leu.2401043","article-title":"Review of alterations of the cyclin-dependent kinase inhibitor INK4 family genes p15, p16, p18 and p19 in human leukemia-lymphoma cells","volume":"12","author":"Drexler","year":"1998","journal-title":"Leukemia"},{"key":"10.1016\/j.leukres.2004.03.019_BIB22","first-page":"832","article-title":"Frequent and selective methylation of p15 and deletion of both p15 and p16 in T-cell acute lymphoblastic leukemia","volume":"57","author":"Batova","year":"1997","journal-title":"Cancer Res"},{"key":"10.1016\/j.leukres.2004.03.019_BIB23","first-page":"1219","article-title":"Universal inactivation of both p16 and p15 but not downstream components is an essential event in the pathogenesis of T-cell acute lymphoblastic leukemia","volume":"6","author":"Omura-Minamisawa","year":"2000","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.leukres.2004.03.019_BIB24","first-page":"837","article-title":"Distinct patterns of inactivation of p15INK4B and p16INK4A characterize the major types of hematological malignancies","volume":"57","author":"Herman","year":"1997","journal-title":"Cancer Res"},{"key":"10.1016\/j.leukres.2004.03.019_BIB25","first-page":"561","article-title":"Methylation of promoter region in p27 gene plays a role in the development of lymphoid malignancies","volume":"22","author":"Nakatsuka","year":"2003","journal-title":"Int J Oncol"},{"key":"10.1016\/j.leukres.2004.03.019_BIB26","first-page":"6335","article-title":"Frequent alterations of the p14(ARF) and p16(INK4a) genes in primary central nervous system lymphomas","volume":"61","author":"Nakamura","year":"2001","journal-title":"Cancer Res"},{"key":"10.1016\/j.leukres.2004.03.019_BIB27","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1002\/pros.1104","article-title":"Methylation and mutational analysis of p27(kip1) genes in prostate carcinoma","volume":"48","author":"Kibel","year":"2001","journal-title":"Prostate"},{"key":"10.1016\/j.leukres.2004.03.019_BIB28","doi-asserted-by":"crossref","first-page":"752","DOI":"10.1097\/01.MP.0000081728.21368.85","article-title":"Methylation analysis of cyclin-dependent kinase inhibitor genes in primary gastrointestinal lymphomas","volume":"16","author":"Go","year":"2003","journal-title":"Mod Pathol"},{"key":"10.1016\/j.leukres.2004.03.019_BIB29","doi-asserted-by":"crossref","first-page":"2291","DOI":"10.1182\/blood.V99.7.2291","article-title":"5\u2032 CpG island hypermethylation is associated with transcriptional silencing of the p21(CIP1\/WAF1\/SDI1) gene and confers poor prognosis in acute lymphoblastic leukemia","volume":"99","author":"Roman-Gomez","year":"2002","journal-title":"Blood"},{"key":"10.1016\/j.leukres.2004.03.019_BIB30","doi-asserted-by":"crossref","first-page":"3432","DOI":"10.1182\/blood-2002-07-1990","article-title":"Lack of p21(CIP1) DNA methylation in acute lymphocytic leukemia","volume":"100","author":"Shen","year":"2002","journal-title":"Blood"},{"key":"10.1016\/j.leukres.2004.03.019_BIB31","doi-asserted-by":"crossref","first-page":"9821","DOI":"10.1073\/pnas.93.18.9821","article-title":"Methylation-specific PCR: a novel PCR assay for methylation status of CpG islands","volume":"93","author":"Herman","year":"1996","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.leukres.2004.03.019_BIB32","doi-asserted-by":"crossref","first-page":"4422","DOI":"10.1093\/nar\/25.21.4422","article-title":"Detection and measurement of PCR bias in quantitative methylation analysis of bisulphite-treated DNA","volume":"25","author":"Warnecke","year":"1997","journal-title":"Nucleic Acids Res"},{"key":"10.1016\/j.leukres.2004.03.019_BIB33","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1182\/blood-2003-09-3193","article-title":"Promoter hypermethylation of the cyclin-dependent kinase inhibitor (CDKI) gene p21WAF1\/CIP1\/SDI1 is rare in various lymphomas and carcinomas","volume":"103","author":"Ying","year":"2004","journal-title":"Blood"},{"key":"10.1016\/j.leukres.2004.03.019_BIB34","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1186\/bcr42","article-title":"Transforming growth factor-beta and breast cancer: Transforming growth factor-beta\/SMAD signaling defects and cancer","volume":"2","author":"Kretzschmar","year":"2000","journal-title":"Breast Cancer Res"},{"key":"10.1016\/j.leukres.2004.03.019_BIB35","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/1359-6101(96)00001-9","article-title":"Tumor suppressor activity of the TGF-beta pathway in human cancers","volume":"7","author":"Markowitz","year":"1996","journal-title":"Cytokine Growth Factor Rev"},{"key":"10.1016\/j.leukres.2004.03.019_BIB36","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1016\/S1470-2045(02)00932-4","article-title":"Epigenetics in cancer: implications for early detection and prevention","volume":"3","author":"Verma","year":"2002","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.leukres.2004.03.019_BIB37","doi-asserted-by":"crossref","first-page":"1205","DOI":"10.1016\/S0889-8588(05)70182-9","article-title":"Adult Acute Lymphocytic Leukemia","volume":"14","author":"Kantarjian","year":"2000","journal-title":"Hematol Oncol Clin North Am"},{"key":"10.1016\/j.leukres.2004.03.019_BIB38","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/S0145-2126(98)00146-5","article-title":"Alterations of the p53, p21, p16, p15 and RAS genes in childhood T-cell acute lymphoblastic leukemia","volume":"23","author":"Kawamura","year":"1999","journal-title":"Leuk Res"},{"key":"10.1016\/j.leukres.2004.03.019_BIB39","doi-asserted-by":"crossref","first-page":"1924","DOI":"10.1182\/blood.V86.5.1924.bloodjournal8651924","article-title":"Alterations of the p27KIP1 gene in non-Hodgkin\u2019s lymphomas and adult T-cell leukemia\/lymphoma","volume":"86","author":"Morosetti","year":"1995","journal-title":"Blood"},{"key":"10.1016\/j.leukres.2004.03.019_BIB40","first-page":"1211","article-title":"p27Kip1: chromosomal mapping to 12p12-12p13.1 and absence of mutations in human tumors","volume":"55","author":"Ponce-Castaneda","year":"1995","journal-title":"Cancer Res"},{"key":"10.1016\/j.leukres.2004.03.019_BIB41","doi-asserted-by":"crossref","first-page":"5111","DOI":"10.1038\/sj.onc.1203891","article-title":"Aberrant p27Kip1 promoter methylation in malignant melanoma","volume":"19","author":"Worm","year":"2000","journal-title":"Oncogene"},{"key":"10.1016\/j.leukres.2004.03.019_BIB42","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1038\/nm0297-231","article-title":"Increased proteasome-dependent degradation of the cyclin-dependent kinase inhibitor p27 in aggressive colorectal carcinomas","volume":"3","author":"Loda","year":"1997","journal-title":"Nat Med"},{"key":"10.1016\/j.leukres.2004.03.019_BIB43","first-page":"3290","article-title":"Inhibition of the interferon-gamma\/signal transducers and activators of transcription (STAT) pathway by hypermethylation at a STAT-binding site in the p21WAF1 promoter region","volume":"60","author":"Chen","year":"2000","journal-title":"Cancer Res"},{"key":"10.1016\/j.leukres.2004.03.019_BIB44","doi-asserted-by":"crossref","first-page":"2445","DOI":"10.1182\/blood.V94.7.2445.419k19_2445_2451","article-title":"p15(INK4B) CpG island methylation in primary acute leukemia is heterogeneous and suggests density as a critical factor for transcriptional silencing","volume":"94","author":"Cameron","year":"1999","journal-title":"Blood"},{"key":"10.1016\/j.leukres.2004.03.019_BIB45","doi-asserted-by":"crossref","first-page":"1108","DOI":"10.1093\/annonc\/mdf185","article-title":"p53 gene mutations are associated with poor survival in low and low-intermediate risk diffuse large B-cell lymphomas","volume":"13","author":"Leroy","year":"2002","journal-title":"Ann Oncol"},{"key":"10.1016\/j.leukres.2004.03.019_BIB46","unstructured":"Yang H, Hoshino K, Canalli A, Sanchez-Gonzalez B, Kantarjian H, Issa JP, Garcia-Manero G, Preclinical Studies of the Combination of the Hypomethylating Agent 5-aza-2-Deoxycytidine (Decitabine) and the Histone Deacetylase Inhibitor (HDI) Valproic Acid (VPA) in Leukemic Cell Systems, Blood 2003;102:Abstract 2295."},{"key":"10.1016\/j.leukres.2004.03.019_BIB47","doi-asserted-by":"crossref","first-page":"22199","DOI":"10.1074\/jbc.272.35.22199","article-title":"Butyrate activates the WAF1\/Cip1 gene promoter through Sp1 sites in a p53-negative human colon cancer cell line","volume":"272","author":"Nakano","year":"1997","journal-title":"J Biol Chem"},{"key":"10.1016\/j.leukres.2004.03.019_BIB48","doi-asserted-by":"crossref","first-page":"6340","DOI":"10.1038\/sj.onc.1205787","article-title":"The ubiquitous and tissue specific promoters of the human SRC gene are repressed by inhibitors of histone deacetylases","volume":"21","author":"Kostyniuk","year":"2002","journal-title":"Oncogene"},{"key":"10.1016\/j.leukres.2004.03.019_BIB49","doi-asserted-by":"crossref","first-page":"10014","DOI":"10.1073\/pnas.180316197","article-title":"Histone deacetylase inhibitor selectively induces p21WAF1 expression and gene-associated histone acetylation","volume":"97","author":"Richon","year":"2000","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.leukres.2004.03.019_BIB50","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1016\/0092-8674(93)90500-P","article-title":"WAF1, a potential mediator of p53 tumor suppression","volume":"75","author":"el-Deiry","year":"1993","journal-title":"Cell"},{"key":"10.1016\/j.leukres.2004.03.019_BIB51","doi-asserted-by":"crossref","first-page":"7982","DOI":"10.1128\/MCB.22.22.7982-7992.2002","article-title":"Runx2 (Cbfa1, AML-3) interacts with histone deacetylase 6 and represses the p21(CIP1\/WAF1) promoter","volume":"22","author":"Westendorf","year":"2002","journal-title":"Mol Cell Biol"},{"key":"10.1016\/j.leukres.2004.03.019_BIB52","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1038\/sj.onc.1206145","article-title":"Myc represses differentiation-induced p21CIP1 expression via Miz-1-dependent interaction with the p21 core promoter","volume":"22","author":"Wu","year":"2003","journal-title":"Oncogene"}],"container-title":["Leukemia Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0145212604001249?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0145212604001249?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,4,2]],"date-time":"2020-04-02T10:43:03Z","timestamp":1585824183000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0145212604001249"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2004,12]]},"references-count":52,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2004,12]]}},"alternative-id":["S0145212604001249"],"URL":"https:\/\/doi.org\/10.1016\/j.leukres.2004.03.019","relation":{},"ISSN":["0145-2126"],"issn-type":[{"value":"0145-2126","type":"print"}],"subject":[],"published":{"date-parts":[[2004,12]]}}}